Skip to content
InsideEdge
Investors / filer profile

Track record

What happened ~6 months after each disclosed buy

+76.0%avg per buy, ~6 months on+4.2%S&P 500 avg, same spans
PASG · 2025-07-22 · +215.9% (S&P +10.5%)PASG · 2025-07-23 · +146.9% (S&P +9.4%)PASG · 2025-07-24 · +164.6% (S&P +8.8%)PASG · 2025-09-11 · +16.5% (S&P +3.6%)PASG · 2025-09-12 · +20.0% (S&P +2.3%)PASG · 2025-09-15 · +26.5% (S&P +2.6%)CGEM · 2025-10-08 · +116.1% (S&P -2.7%)CGEM · 2025-10-09 · +104.7% (S&P -2.3%)CGEM · 2025-10-10 · +101.6% (S&P +0.9%)CGEM · 2025-10-14 · +93.3% (S&P +2.1%)CGEM · 2025-10-15 · +76.2% (S&P +2.2%)CGEM · 2025-10-16 · +66.4% (S&P +2.8%)CGEM · 2025-10-17 · +81.4% (S&P +3.3%)NEUP · 2025-10-21 · -4.1% (S&P +4.3%)CGEM · 2025-10-28 · +63.0% (S&P +3.5%)TCRX · 2025-12-19 · +6.0% (S&P +10.3%)TCRX · 2025-12-22 · -2.3% (S&P +9.6%)
2025-07-222025-12-22
Each dot: one completed buy’s ~6-month outcome, equal weight per buy · dashed: S&P 500 over the same spans · hover a dot for detail
15 of 17
buys higher ~6mo later
+76.2%
median outcome
+3.3%
S&P 500 median, same spans

1 buy still inside the ~6-month window — not scored yet.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$150.63M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$8.9M$17.7M2025 · bought $17.7M · sold $02025
Total +$17.71M bought

All filings on record

Every Form 4 transaction we track for this filer

TCRXBuy
2025-12-23 · TScan Therapeutics, Inc.
$5.6K
in progress
TCRXBuy
2025-12-22 · TScan Therapeutics, Inc.
$68.0K
-2.3%
TCRXBuy
2025-12-19 · TScan Therapeutics, Inc.
$72.0K
+6.0%
CGEMBuy
2025-10-28 · Cullinan Therapeutics, Inc.
$1.39M
+63.0%
NEUPBuy
2025-10-21 · Neuphoria Therapeutics Inc.
$3.28M
-4.1%
CGEMBuy
2025-10-17 · Cullinan Therapeutics, Inc.
$252.6K
+81.4%
CGEMBuy
2025-10-16 · Cullinan Therapeutics, Inc.
$1.33M
+66.4%
CGEMBuy
2025-10-15 · Cullinan Therapeutics, Inc.
$409.0K
+76.2%
CGEMBuy
2025-10-14 · Cullinan Therapeutics, Inc.
$114.0K
+93.3%
CGEMBuy
2025-10-10 · Cullinan Therapeutics, Inc.
$2.04M
+101.6%
CGEMBuy
2025-10-09 · Cullinan Therapeutics, Inc.
$4.19M
+104.7%
CGEMBuy
2025-10-08 · Cullinan Therapeutics, Inc.
$3.59M
+116.1%
PASGBuy
2025-09-15 · Passage BIO, Inc.
$83.2K
+26.5%
PASGBuy
2025-09-12 · Passage BIO, Inc.
$138.3K
+20.0%
PASGBuy
2025-09-11 · Passage BIO, Inc.
$2.3K
+16.5%
PASGBuy
2025-07-24 · Passage BIO, Inc.
$379.5K
+164.6%
PASGBuy
2025-07-23 · Passage BIO, Inc.
$283.0K
+146.9%
PASGBuy
2025-07-22 · Passage BIO, Inc.
$71.3K
+215.9%

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.